Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

1.80
-0.0300-1.64%
Post-market: 1.74-0.0600-3.33%18:11 EST
Volume:804.65K
Turnover:1.45M
Market Cap:3.63M
PE:-0.09
High:1.96
Open:1.80
Low:1.64
Close:1.83
52wk High:28.60
52wk Low:1.52
Shares:2.02M
Float Shares:1.81M
Volume Ratio:0.43
T/O Rate:44.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.9641
EPS(LYR):-18.2923
ROE:-436.14%
ROA:-136.26%
PB:-5.74
PE(LYR):-0.10

Loading ...

Company Profile

Company Name:
Artelo Biosciences, Inc.
Exchange:
NASDAQ
Establishment Date:
2011
Employees:
6
Office Location:
505 Lomas Santa Fe,Suite 160,Solana Beach,California,United States
Zip Code:
92075
Fax:
- -
Introduction:
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Directors

Name
Position
Gregory D. Gorgas
President, Chief Executive Officer, Secretary and Director
Connie Matsui
Director and Chairperson of the Board
Douglas Blayney
Director
Gregory Reyes
Director
R. Martin Emanuele
Director
Steven Kelly
Director
Tamara A. Favorito
Director

Shareholders

Name
Position
Gregory D. Gorgas
President, Chief Executive Officer, Secretary and Director
Mark Spring
Chief Financial Officer, Treasurer and Principal Accounting Officer